Daniel Herman, founder of Bio-Synergy, a UK-based sports nutrition and supplement business established in 1997, has seen many fads come and go over the years, but believes the GLP-1 movement is here to stay
*Your clinician will determine which format is right for you based on your labs, health history, and treatment goals
Thus, an investigation into the effects of each agent may be necessary
Yes, GLP-1based medications have received FDA approval for weight loss treatment
Altogether, about 1 in 8 US adults say they're currently taking one of the medicines, according to data from health policy research group KFF
These results are consistent with previous reports in which GLP-1 and GLP-1R agonists cause transient increases in MAP and HR in both normotensive and hypertensive rodents [10, 13, 17, 57, 58]